BREMAZOCINE
UNII ISF76M2DBE

Substance Identification & Data

This profile provides standardized clinical and technical data for Bremazocine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ISF76M2DBE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 83829-76-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ISF76M2DBE

CAS Registry Number

83829-76-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BREMAZOCINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C20H29NO2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZDXGFIXMPOUDFF-XLIONFOSSA-N;ZDXGFIXMPOUDFF-FXAWDEMLSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C91041

National Cancer Institute reference terminology for clinical and research data.

INN ID

4849

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1N([C@@H]2Cc3c(cc(cc3)O)[C@@](C1)(CC)C2(C)C)CC4(CC4)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bremazocine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.